Replies to post #83 on Biosyent Inc (RX)

[MikeDDKing]

According to my calculations, BioSyent had a 9th consecutive quarter of sequentially increasing pharmaceutical sales. Pharmaceutical sales were roughly $656K. Insecticide sales were only roughly $47K. Q4 is the seasonally slow period for insecticide sales and this year Q4 insecticide sales came in lighter like they did in 2009.

My estimate for 2012 is for diluted EPS of $0.10/share.

[Rawnoc]

Expected. You don't sell as much bug spray under 12 feet of snow as you do under 100 degree heat. YOY numbers more relevant as well as pharmaceutical numbers which were up sequentially.